BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6713380)

  • 1. Effects of the antitumor agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one on the DNA of mouse L1210 cells.
    Gibson NW; Erickson LC; Hickman JA
    Cancer Res; 1984 May; 44(5):1767-71. PubMed ID: 6713380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one.
    Gibson NW; Hickman JA; Erickson LC
    Cancer Res; 1984 May; 44(5):1772-5. PubMed ID: 6713381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of N-(2-chloroethyl)-N-nitrosoureas with DNA: effect of buffers on DNA adduction, cross-linking, and cytotoxicity.
    Chen FX; Bodell WJ; Liang G; Gold B
    Chem Res Toxicol; 1996; 9(1):208-14. PubMed ID: 8924592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
    Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the mechanism of action of busulfan with hepsulfam, a new antileukemic agent, in the L1210 cell line.
    Pacheco DY; Stratton NK; Gibson NW
    Cancer Res; 1989 Sep; 49(18):5108-10. PubMed ID: 2766282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.
    Stevens MF; Hickman JA; Langdon SP; Chubb D; Vickers L; Stone R; Baig G; Goddard C; Gibson NW; Slack JA
    Cancer Res; 1987 Nov; 47(22):5846-52. PubMed ID: 3664486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
    Richardson ME; Siemann DW
    Cancer Res; 1995 Apr; 55(8):1691-5. PubMed ID: 7712476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent.
    Stevens MF; Hickman JA; Stone R; Gibson NW; Baig GU; Lunt E; Newton CG
    J Med Chem; 1984 Feb; 27(2):196-201. PubMed ID: 6694168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.
    Hickman JA; Stevens MF; Gibson NW; Langdon SP; Fizames C; Lavelle F; Atassi G; Lunt E; Tilson RM
    Cancer Res; 1985 Jul; 45(7):3008-13. PubMed ID: 4005840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
    DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
    Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pharmacology of the anthracycline drug 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (Cl 216,942).
    Bowden GT; Garcia D; Peng YM; Alberts DS
    Cancer Res; 1982 Jul; 42(7):2660-5. PubMed ID: 7083158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of mitomycin C with mammalian DNA detected by alkaline elution.
    Dorr RT; Bowden GT; Alberts DS; Liddil JD
    Cancer Res; 1985 Aug; 45(8):3510-6. PubMed ID: 3926301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity.
    Zwelling LA; Anderson T; Kohn KW
    Cancer Res; 1979 Feb; 39(2 Pt 1):365-9. PubMed ID: 570092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-protein cross-linking and DNA interstrand cross-linking by haloethylnitrosoureas in L1210 cells.
    Ewig RA; Kohn KW
    Cancer Res; 1978 Oct; 38(10):3197-203. PubMed ID: 150940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of N,N',N''-triethylenethiophosphoramide and N,N',N''-triethylenephosphoramide with cellular DNA.
    Cohen NA; Egorin MJ; Snyder SW; Ashar B; Wietharn BE; Pan SS; Ross DD; Hilton J
    Cancer Res; 1991 Aug; 51(16):4360-6. PubMed ID: 1714342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of misonidazole on the cytotoxicity and DNA cross-linking activity of an activated sulfidocyclophosphamide in hypoxic mouse leukemia cells.
    Ramonas LM; Erickson LC; McManus ME
    Mol Pharmacol; 1982 Jul; 22(1):175-81. PubMed ID: 7121448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Hilton J; Bowie DL; Gutin PH; Zito DM; Walker MD
    Cancer Res; 1977 Jul; 37(7 Pt 1):2262-6. PubMed ID: 861950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II).
    Zwelling LA; Kohn KW; Ross WE; Ewig RA; Anderson T
    Cancer Res; 1978 Jun; 38(6):1762-8. PubMed ID: 565680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective DNA interaction of the novel distamycin derivative FCE 24517.
    Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
    Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.